About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

RECRUITINGNANCT06095297

Long COVID Brain Fog: Cognitive Rehabilitation Trial

This study will compare two approaches to cognitive rehabilitation in adults with long COVID with persistent, mild to moderate, cognitive impairment. One approach will feature (A) web-based computer "...

Lead sponsor: University of Alabama at Birmingham•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Madeline Rathz, BS

CONTACT

205-934-9768 mgrathz@uab.edu

Helen Bliss, BS

CONTACT

205-934-0433 hmbliss@uab.edu

Sponsors

Lead Sponsor

University of Alabama at Birmingham

Collaborators

National Institute on Disability, Independent Living, and Rehabilitation Research
Posit Science

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•\>3 months post COVID
•mild or greater cognitive impairment
•moderate or greater brain fog
•impairment in performance of daily activities
•reside in community
•reliable transportation to lab
•sufficiently mentally and physically fit
•adequate sight and hearing
•ability to follow directions, and retain information
•sufficient English proficiency

Exclusion Criteria

•cognitive impairment due to developmental disability, psychiatric disorder, or substance abuse, TBI or progressive brain disease
•stroke prior to the onset of COVID
•current substance abuse disorder
•prior cognitive processing speed training on DoubleDecision or similar program
•cannot tolerate trans-auricular vagus nerve stimulation

Related studies

A SMART Trial of Adaptive Exercises to Optimize Aerobic-Fitness Responses

NCT05877196 · Mild Cognitive Impairment, Alzheimer Disease, and more

RECRUITINGPhase 3

Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID

NCT06631287 · Long COVID, Sars-CoV-2 Infection, and more

Essential Fats For Enhancing Cognitive Thinking (EFFECT) Study

NCT06223672 · Cognitive Decline, Cognitive Impairment

Evaluating the Impact of a Functional and Cognitive Strategy in Patients With Long Covid-19

NCT06871293 · Long COVID-19 Syndrome, COVID 19, and more

Feasibility Study of 'SuperBrain BOOM' for Mild Cognitive Impairment Patients

NCT07101380 · Mild Cognitive Impairment (MCI)

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 13, 2026Terms

Trial snapshot

StatusRECRUITING

PhaseNA

Enrollment30

Start dateApr 2024

Last updatedApr 13, 2026

Condition

Long COVID Brain Fog Cognitive Impairment Cognitive Dysfunction Post-Acute COVID-19 Syndrome

Locations shown

University of Alabama at Birmingham

Birmingham, Alabama

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 13, 2026Data synced to Clareo: May 17, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions